|
BCKDHA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.99209999793982E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.43179999973131E-08 |
| Normal-vs-Stage2 |
2.950800E-01 |
| Normal-vs-Stage3 |
2.902900E-03 |
| Normal-vs-Stage4 |
1.70730000026431E-07 |
| Stage1-vs-Stage2 |
3.480400E-02 |
| Stage1-vs-Stage3 |
7.913000E-01 |
| Stage1-vs-Stage4 |
1.522200E-01 |
| Stage2-vs-Stage3 |
1.430250E-01 |
| Stage2-vs-Stage4 |
5.560300E-03 |
| Stage3-vs-Stage4 |
2.176600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.35830000031123E-07 |
| Normal-vs-AfricanAmerican |
3.252400E-01 |
| Normal-vs-Asian |
5.6451000540747E-09 |
| Caucasian-vs-AfricanAmerican |
1.889000E-01 |
| Caucasian-vs-Asian |
9.825700E-02 |
| AfricanAmerican-vs-Asian |
3.872300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.118230E-02 |
| Normal-vs-Female |
6.96650004350374E-09 |
| Male-vs-Female |
2.760600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.22529997259591E-09 |
| Normal-vs-Age(41-60Yrs) |
2.75339999999957E-06 |
| Normal-vs-Age(61-80Yrs) |
6.998600E-04 |
| Normal-vs-Age(81-100Yrs) |
6.642200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.329430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.817900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.952600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.368200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.465400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.757600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.554400E-04 |
| Classical-VS-Follicular |
6.315800E-03 |
| Classical-VS-Other |
7.988200E-01 |
| Classical-VS-Normal |
2.8526000006579E-08 |
| Tall-VS-Follicular |
2.5809000003818E-07 |
| Tall-VS-Other |
5.229800E-01 |
| Tall-VS-Normal |
4.51716442029237E-12 |
| Follicular-VS-Other |
2.478400E-01 |
| Follicular-VS-Normal |
1.033750E-01 |
| Other-VS-Normal |
1.307420E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.623900E-03 |
| Normal-vs-N1 |
2.18491891246231E-13 |
| N0-vs-N1 |
2.4439000001486E-07 |
|
|
